MSmonitor-plus program and video calling care (MPVC) for multidisciplinary care and self-management in multiple sclerosis: study protocol of a single-center randomized, parallel-group, open label, non-inferiority trial

被引：0
|
作者：
M. Hoving
P. J. Jongen
S. M. A. A. Evers
M. A. Edens
E. M. P. E. Zeinstra
机构：
[1] Isala Hospital,Multiple Sclerosis Center, Department of Neurology
[2] Maastricht University,Department of Health Services Research (HRS), Care and Public Health Research Institute (CAPHRI)
[3] MS4 Research Institute,Department of Health Sciences
[4] University Medical Center Groningen and University of Groningen,Epidemiology Unit, Department of Innovation and Science
[5] Trimbos Institute,undefined
[6] Netherlands Institute of Mental Health and Addiction,undefined
[7] Centre of Economic Evaluation & Machine Learning,undefined
[8] Isala Hospital,undefined
来源：
BMC Neurology | / 22卷
关键词：
Multiple sclerosis; MSmonitor; Quality of life; MSmonitor-plus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 7 条
  • [1] MSmonitor-plus program and video calling care (MPVC) for multidisciplinary care and self-management in multiple sclerosis: study protocol of a single-center randomized, parallel-group, open label, non-inferiority trial
    Hoving, M.
    Jongen, P. J.
    Evers, S. M. A. A.
    Edens, M. A.
    Zeinstra, E. M. P. E.
    BMC NEUROLOGY, 2022, 22 (01)
  • [2] A single-center, single-blinded, randomized, parallel-group, non-inferiority trial to compare the efficacy of a 22-gauge needle versus a 15 blade to perform an Achilles tendon tenotomy in 244 clubfeet—study protocol
    Manon Pigeolet
    Jabbar Ghufran Syed
    Sadia Ahmed
    Muhammad Amin Chinoy
    Mansoor Ali Khan
    Trials, 24
  • [3] A single-center, single-blinded, randomized, parallel-group, non-inferiority trial to compare the efficacy of a 22-gauge needle versus a 15 blade to perform an Achilles tendon tenotomy in 244 clubfeet-study protocol
    Pigeolet, Manon
    Syed, Jabbar Ghufran
    Ahmed, Sadia
    Chinoy, Muhammad Amin
    Khan, Mansoor Ali
    TRIALS, 2023, 24 (01)
  • [4] Feasibility of diabetes self-management coaching program for individuals with type 2 diabetes in the Ethiopian primary care setting: a protocol for a feasibility mixed-methods parallel-group randomized controlled trial
    Yehualashet, Fikadu Ambaw
    Kessler, Dorothy
    Bizuneh, Segenet
    Donnelly, Catherine
    PILOT AND FEASIBILITY STUDIES, 2024, 10 (01)
  • [5] Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled Trial
    Zhang, Fang
    Tang, Lizhi
    Li, Jing
    Yan, Zhe
    Li, Juan
    Tong, Nanwei
    DIABETES METABOLIC SYNDROME AND OBESITY, 2021, 14 : 1243 - 1252
  • [6] Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial
    Toshimasa Shimizu
    Shin-ya Kawashiri
    Shimpei Morimoto
    Yurika Kawazoe
    Shohei Kuroda
    Rina Kawasaki
    Yasuko Ito
    Rieko Kiya
    Shuntaro Sato
    Hiroshi Yamamoto
    Atsushi Kawakami
    Trials, 24
  • [7] Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial
    Shimizu, Toshimasa
    Kawashiri, Shin-ya
    Morimoto, Shimpei
    Kawazoe, Yurika
    Kuroda, Shohei
    Kawasaki, Rina
    Ito, Yasuko
    Kiya, Rieko
    Sato, Shuntaro
    Yamamoto, Hiroshi
    Kawakami, Atsushi
    TRIALS, 2023, 24 (01)
1